The Scientific Advisory Team at Applied Genetics Technologies Corporation (AGTC) provides expert guidance and strategic insights on the development and implementation of AAV-based gene therapies for the treatment of rare diseases. Consisting of founders and scientific advisors, the team collaborates to ensure cutting-edge research and clinical trials adhere to the highest scientific and ethical standards.
Barry Byrne
Founder & Scientific Advisor
David G. Birch
Scientific Advisor
Gregory S. Hageman
Scientific Advisor
J. Timothy Stout
Scientific Advisor
Karl G. Csaky
Scientific Advisor
Nicholas Muzyczka
Founder & Scientific Advisor
Peter A. Campochiaro
Scientific Advisor
R. Jude Samulski
Founder & Scientific Advisor
Stephen P. Daiger
Scientific Advisor
Terence Flotte
Founder & Scientific Advisor
View all